Feeds
Sanofi-Aventis and Regeneron Pharmaceuticals Inc. said Tuesday they expanded an existing development partnership to run through 2017.
French drugmaker Sanofi-Aventis says it is promoting two high-ranking executives and adding a third to its executive committee.
Sanofi-Aventis is paying privately-held Wellstat Therapeutics Corp. up to $350 million under terms of a licensing deal for a potential diabetes drug, the companies said Wednesday.
Drug developer Sanofi-Aventis says it will close its Kansas City, Mo., plant by 2012, citing a decline in demand for products made at the site.
Pharmaceuticals company Sanofi-Aventis SA said Thursday it has agreed to pay $4 billion in cash to U.S. drugmaker Merck & Co. Inc. for its share in the two companies' animal health joint venture Merial.
Sanofi Pasteur, a unit of Paris-based Sanofi-Aventis, said Monday it started shipping its seasonal flu vaccine Fluzone for the next flu season.
The French government has ordered 28 million doses of swine flu vaccine from Sanofi Pasteur, parent company Sanofi-Aventis SA said Thursday.
The Food and Drug Administration said Wednesday it is reviewing data on the safety of Lantus, a synthetic insulin made by Sanofi-Aventis SA.
French drugmaker Sanofi-Aventis SA announces a major corporate restructuring on the heels of new safety concerns that could hurt sales of a key drug, its once-a-day insulin Lantus.
Sanofi-Aventis SA has agreed to pay up to $500 million to buy California-based BiPar Sciences in a move to strengthen its research and development in cancer treatments, the Paris-based pharmaceutical company said Wednesday.
Drug maker Sanofi-Aventis SA said Wednesday its fourth quarter net profit plummeted 76 percent from a year earlier due mainly to a charge taken for discontinuing two experimental cancer drugs.
Sanofi-Aventis SA said Wednesday that its top legal and financial officer has stepped down, and that two executives will inherit each of his former roles at the French pharmaceuticals giant.
French drugmaker Sanofi-Aventis SA is cutting an unspecified number of U.S. sales jobs as part of a realignment of its marketing.
Sanofi-Aventis SA said Wednesday it has settled lawsuits against rival drugmakers it accused of infringing on its patents in the United States with their generic versions of its allergy treatments Allegra and Nasacort.
French drugmaker Sanofi-Aventis is halting all research on a once-promising diet drug that never made it to the U.S. market.
French pharmaceutical giant Sanofi-Aventis said Friday that higher sales of blood thinners Lovenox and Plavix and diabetes treament Lantus helped lift net profit by 1.9 percent in the third quarter.
French pharmaceutical company Sanofi-Aventis temporarily suspended sales of anti-obesity drug Acomplia in Europe, the company said Thursday, after health authorities said the drug's risks outweigh its benefits.
Sanofi-Aventis stunned investors Wednesday with its surprise decision to hire Chris Viehbacher to take over as chief executive with a mandate to shake up the French drug maker's strategy.
Buffett's State of the World: There's Folly in WonderlandWarren Buffett's annual letter to shareholders, which was released Friday, has become something of a business institution, with the hope that he will shed light on his investments.
Vaccine Companies Investigated for ManslaughterFrom French judges probe firms over vaccinations
Sales of Stints, Syringes and Drugs, Drive Pharma Profits Beyond ExpectationsAs illness soars skyward, so does the revenue of the bio-pharma sector. No longer are syruinges limited to doctors, hospitals.
F.D.A. Panel Rejects Rimonabant, Drug for Obesity: A drug once viewed as a possible magic bullet against obesity was rejected yesterday by a federal advisory panel because of worries that it causes neurological and psychiatric problems and increases the risk of suicide. Skip to next paragraph Related F.D.A.
First Vaccine Against Avian Flu Is Approved as Interim MeasureThe vaccine, approved for adults 18 to 64, will not be available for sale to the general public. It will be dispensed only by the government in the event of a pandemic under rules that have yet to be fully worked out.
Lawmakers blast FDA drug safety oversightU.S. lawmakers criticized the Food and Drug Administration's monitoring of the risks of a Sanofi-Aventis antibiotic and some other prescription drugs on Tuesday.
Another blow for big pharma?Medical and biotechnology IP battles, while less visible than the name-calling campaigns of electronic companies, remain as fierce as ever.
Log In | Register
